Factors associated with renewal outcomes for anti-cancer drugs in China's national reimbursement drug list negotiation: a retrospective observational study
{{output}}
Background: Price negotiation improves access to innovative anti-cancer drugs in China but pressures healthcare funds. Renewal negotiation balances cost and access, with success defined as entering a new two-year agreement after ... ...
